Abbott Labs Q2 profit grows 11% on drug sales in emerging markets

( – Drug and medical device maker Abbott Laboratories reported Wednesday that sales of drugs and nutritionals in emerging markets led to an 11 percent rise in its second-quarter profit, leading the company to raise its full-year earnings guidance.

Leave a Reply

Your email address will not be published.